Akums Drugs and Pharmaceuticals Limited (AKUMS) โ Announcement | 24 August 2026
Akums Drugs and Pharmaceuticals announced that its management cannot attend the scheduled Antique Stock Broking investor-analyst meet on August 25, 2026, due to medical reasons, leading to cancellation of its participation.
About Akums Drugs and Pharmaceuticals Limited (AKUMS)
Healthcare ยท Pharmaceuticals ยท Listed on NSE
๐ก Get AI alerts when AKUMS files next
Free โข Daily 5 PM digest โข Track filings, board meetings, and corporate actions
Track AKUMS โ Free๐ก Ask AI about this filing
๐ More AKUMS filings
- Announcement โ 25 September 2026Akums Drugs & Pharmaceuticals announced that its insider trading compliance window closes on October...
- ๐ด Announcement โ 23 September 2026Akums Drugs & Pharmaceuticals announced its schedule for two institutional investor meetings on Sept...
- ๐ด Announcement โ 16 September 2026Akums Drugs & Pharmaceuticals announced its participation in a scheduled investor and analyst meet o...
- ๐ด Announcement โ 3 September 2026Akums Drugs & Pharmaceuticals announced it received an ESG rating of 65 from NSE Sustainability for ...
- Announcement โ 25 August 2026Akums Drugs and Pharmaceuticals announced its participation in scheduled investor and analyst meetin...
๐ฅ Also filed on 24 August 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only โ not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
๐ก Get AI alerts when AKUMS files new disclosures
Track AKUMS filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track AKUMS โ FreeFree account ยท 2 AI queries/day